Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population

Abstract

Background and Purpose— Guideline adherent oral anticoagulant (OAC) management of patients with nonvalvular atrial fibrillation has been associated with improved outcomes, but limited data are available from Asia. We aimed to investigate outcomes in patients who received guideline compliant management compared with those who were OAC undertreated or overtreated, in a large nationwide multicenter cohort of patients with nonvalvular atrial fibrillation in Thailand. Methods— Patients with nonvalvular atrial fibrillation were prospectively enrolled from 27 hospitals—all of which are data contributors to the COOL-AF Registry (Cohort of Antithrombotic Use and Optimal INR Level in Patients With Non-Valvular Atrial Fibrillation in Thailand). Patients were categorized as follows: (1) guideline adherence group when OAC was given in high-risk or intermediate-risk, but not in low-risk patients; (2) undertreatment group when OAC was not given in the high-risk or intermediate-risk groups; and (3) overtreatment group when OAC was given in the low-risk group or when OAC was given in combination with antiplatelets without indication. Results— A total of 3327 patients who had follow-up clinical outcome data were included. The mean age of patients was 67.4 years and 58.1% were male. The numbers of patients in the guideline adherence group, undertreatment group, and overtreatment group were 2267 (68.1%), 624 (18.8%), and 436 (13.1%) patients, respectively. The overall rate of ischemic stroke, major bleeding, all bleeding, and death was 3.0%, 4.4%, 15.1%, and 7.8%, respectively. Undertreated patients had a higher risk of ischemic stroke and death compared with guideline adherent patients, and overtreated patients had a higher risk of bleeding and death compared with OAC guideline-managed patients. Conclusions— Adherence to OAC management guidelines is associated with improved clinical outcomes in Asian nonvalvular atrial fibrillation patients. Undertreatment or overtreatment was found to be associated with increased risk of adverse outcomes compared with guideline-adherent management.

A Cohort Study on the Safety and Efficacy of Warfarin and Rivaroxaban in Anticoagulant Therapy in Patients with Atrial Fibrillation Study

“…When the attack of AF lasts for more than 48 hours, it is very easy to form mural thrombus in the heart [ 16 ]. At present, it is considered that there are three main factors leading to thrombosis induced by AF: injury of cardiac endothelium, hemodynamic changes, and abnormal blood composition [ 17 ].…”

Evidence-based public policy making for medicines across countries: findings and implications for the future

“…This controversy contrasts with multiple studies that have shown that adherence to robust clinical guidelines improves patient outcomes [178][179][180][181][182]. Table 2 contains details of activities across countries to enhance adherence to guidelines and their impact to guide future activities.…”

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis

“…A previous U.S. national registry study reported that overdose of DOACs was closely related to increased all-cause mortality, whereas underdose was associated with increased cardiovascular disease-related hospitalization ( Steinberg et al, 2016 ). It was also reported that dose adherence to the guideline is associated with improved clinical outcomes in Asian AF patients compared with under- or overtreatment ( Krittayaphong et al, 2020 ).…”